Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
Iván Martínez‐Baz, Ana Miqueleiz, Itziar Casado, et al.
Eurosurveillance (2021) Vol. 26, Iss. 21
Open Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers
Billy J. Gardner, A. Marm Kilpatrick
Viruses (2024) Vol. 16, Iss. 3, pp. 479-479
Open Access | Times Cited: 4
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz, et al.
Eurosurveillance (2022) Vol. 27, Iss. 21
Open Access | Times Cited: 21
The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis
Xiu Hong Yang, Wen Jing Bao, Hua Zhang, et al.
Journal of General Internal Medicine (2023)
Open Access | Times Cited: 11
Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain
Víctor López de Rioja, Luca Basile, Aida Perramon‐Malavez, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 466-466
Open Access | Times Cited: 3
Efectividad y seguridad de las vacunas para el SARS-CoV-2 actualmente disponibles
José Javier Gómez Marco, M.J. Álvarez Pasquín, Susana Martín Martín
FMC - Formación Médica Continuada en Atención Primaria (2021) Vol. 28, Iss. 8, pp. 442-451
Open Access | Times Cited: 24
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)
Sarah M. Hatcher, Stacy Endres‐Dighe, Frederick J. Angulo, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 393-393
Open Access | Times Cited: 12
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021
Ausenda Machado, Irina Kislaya, Ana Paula Rodrigues, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274008-e0274008
Open Access | Times Cited: 12
Knowledge, Attitudes, and Acceptance of COVID-19 Vaccines among Secondary School Pupils in Zambia: Implications for Future Educational and Sensitisation Programmes
Steward Mudenda, Moses Mukosha, Brian Godman, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2141-2141
Open Access | Times Cited: 12
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations: a modeling study
Billy J. Gardner, A. Marm Kilpatrick
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 17
COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients: A Cross-Sectional Study and the Implications for Pakistan and Beyond
Zara Amjad, Iqra Maryam, Maria Munir, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 904-904
Open Access | Times Cited: 6
Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022
Irina Kislaya, Alexis Sentís, Jostein Starrfelt, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 11
Open Access | Times Cited: 5
COVID-19 vaccination challenges: A mini-review
Zeinab Mohseni Afshar, Mohammad Barary, Rezvan Hosseinzadeh, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 9
Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January–May 2021, Aragon, Spain
Alicia del Cura-Bilbao, Héctor López-Mendoza, Armando Chaure-Pardos, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 591-598
Open Access | Times Cited: 8
COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain
Clara Mazagatos, Concepción Delgado‐Sanz, Susana Monge, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 6, pp. 1014-1025
Open Access | Times Cited: 8
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 58-58
Open Access | Times Cited: 1
On the association between COVID-19 vaccination levels and incidence and lethality rates at a regional scale in Spain
Álvaro Briz‐Redón, Ángel Serrano‐Aroca
Stochastic Environmental Research and Risk Assessment (2022) Vol. 36, Iss. 9, pp. 2941-2948
Open Access | Times Cited: 7
SARS-CoV-2 vaccination in patients receiving kidney replacement therapies: where are we now with the protective immune response?
Néstor Toapanta, Oriol Bestard, María José Soler
Nephrology Dialysis Transplantation (2021) Vol. 36, Iss. 10, pp. 1950-1954
Open Access | Times Cited: 10
Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain
Jacobo Pardo‐Seco, Narmeen Mallah, Luis Ricardo López-Pérez, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4039-4039
Open Access | Times Cited: 6
Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
Megan Wallace, Jennifer P. Collins, Heidi L Moline, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278624-e0278624
Open Access | Times Cited: 6
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
COVID-19 infections, hospitalizations, and mortality in Navarre (Spain) between February 2020 and September 2022
Itziar Casado, Manuel García Cenoz, Nerea Egüés, et al.
Anales del Sistema Sanitario de Navarra (2023) Vol. 46, Iss. 2
Open Access | Times Cited: 3
Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study
Iván Martínez‐Baz, Vanessa Bullón‐Vela, Núria Soldevila, et al.
JMIR Research Protocols (2023) Vol. 12, pp. e52114-e52114
Open Access | Times Cited: 3
Supervivencia de los trabajadores de salud infectados por SARS-CoV-2 en el contexto de la vacunación contra la COVID-19 en el Perú
Stefan Escobar-Agreda, Javier Silva‐Valencia, Leonardo Rojas-Mezarina, et al.
Anales de la Facultad de Medicina (2021) Vol. 82, Iss. 2
Open Access | Times Cited: 8
Hacia el control de la COVID-19 a través de la vacunación: obstáculos, desafíos y oportunidades. Informe SESPAS 2022
Pere Godoy, Jesús Castilla, Jenaro Astray, et al.
Gaceta Sanitaria (2022) Vol. 36, pp. S82-S86
Open Access | Times Cited: 5

Scroll to top